Six professors receive UCLA Public Impact Research Awards

The Office of Research & Creative Activities is honoring faculty for work that connects campus to local and global communities

Spanning work that could help Los Angeles meet skyrocketing demands for housing to research that uses big data to help build a more just society for communities of color to multiple projects related to climate change, UCLA faculty are doing work that has clear and immediate benefits to local and international communities.

  • May 19, 2022

Facial feminization surgery gives Chloe Corcoran new joy for life

‘I just wanted to look like me,’ says the UCLA Health patient, who underwent the series of procedures in 2021

"It's just about feeling like me and seeing that in the mirror," says Chloe Corocoran, after her facial feminization procedure. (Photo courtesy of Chloe Corcoran)

Chloe Corcoran waited years — all her life, really — to see herself in the mirror.

After undergoing facial gender-affirming surgery at UCLA Health, she finally can.

“I just wanted to look like me,” says the 40-year-old New York native.

  • May 19, 2022

Guidance for parents amid infant formula shortage

‘My advice is not to panic. Work with your health care provider or your pediatrician to navigate this,’ says UCLA Health’s Dr. Kara Calkins

In the midst of a national infant formula shortage, UCLA Health doctors are warning against homemade recipes or diluting bottles, and advised that pediatricians can help locate supply for babies with special health needs.

  • May 18, 2022

UCLA researchers develop base editing approach for rare genetic immune disorder

New research indicates the novel gene editing technique base editing could be used as a one-time therapy to restore the production of T cells in patients born with the rare genetic immune disorder CD3 delta severe combined immunodeficiency.

This condition, also known as CD3 delta SCID, is caused by a mutation in the CD3 delta gene, which produces a protein by the same name that is critical to the formation of T cells. Babies born with CD3 delta SCID are unable to produce these white blood cells that fight against disease-causing intruders in the body.